| Title |
Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy
|
|---|---|
| Published in |
Journal of Neuro-Oncology, September 2010
|
| DOI | 10.1007/s11060-010-0403-6 |
| Pubmed ID | |
| Authors |
David A. Reardon, Annick Desjardins, Katherine Peters, Sridharan Gururangan, John Sampson, Jeremy N. Rich, Roger McLendon, James E. Herndon, Jennifer Marcello, Stevie Threatt, Allan H. Friedman, James J. Vredenburgh, Henry S. Friedman |
Mendeley readers
The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 1% |
| China | 1 | 1% |
| France | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 69 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 23% |
| Student > Bachelor | 10 | 14% |
| Student > Ph. D. Student | 9 | 12% |
| Student > Master | 8 | 11% |
| Other | 5 | 7% |
| Other | 9 | 12% |
| Unknown | 15 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 33 | 45% |
| Neuroscience | 6 | 8% |
| Agricultural and Biological Sciences | 5 | 7% |
| Mathematics | 3 | 4% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Other | 3 | 4% |
| Unknown | 20 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2018.
All research outputs
#7,473,822
of 22,849,304 outputs
Outputs from Journal of Neuro-Oncology
#1,045
of 2,972 outputs
Outputs of similar age
#34,570
of 96,601 outputs
Outputs of similar age from Journal of Neuro-Oncology
#7
of 19 outputs
Altmetric has tracked 22,849,304 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,972 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 48th percentile – i.e., 48% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,601 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.